Akatsuka Kyoko, Hatta Taichi, Sawai Tsutomu, Fujita Misao
Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Front Genet. 2023 Jun 22;14:1205067. doi: 10.3389/fgene.2023.1205067. eCollection 2023.
Multiple surveys of the general public and experts on human genome editing have been conducted. However, many focused only on editing in clinical applications, with few regarding its use for basic research. Given that genome editing for research purposes is indispensable for the realization of clinical genome editing, understanding lay attitudes toward genome editing in research, particularly using human embryos, which is likely to provoke ethical concerns, is helpful for future societal discussion. An online survey was conducted with Japanese laypeople and researchers to ascertain their views regarding human genome editing for research purposes. Participants were queried about their acceptance as a function of the target of genome editing (germ cells, surplus IVF embryos, research embryos, somatic cells); then, those who answered "acceptable depending on the purpose" were asked about their acceptance in the context of specific research purposes of genome editing. Participants were also asked about their expectations and concerns regarding human genome editing. Replies were obtained from 4,424 laypeople and 98 researchers. Approximately 28.2-36.9% of the laypeople exhibited strong resistance to genome editing for research purposes regardless of their applications. In contrast, 25.5% of the researchers demonstrated resistance only to genome editing in research embryos; this percentage was substantially higher than those concerning the other three targets (5.1-9.2%). Approximately 50.4-63.4% of laypeople who answered "acceptable depending on the purpose" approved germline genome editing for disease research; however, only 39.3-42.8% approved genome editing in basic research to obtain biological knowledge. In contrast, the researchers displayed a lower degree of acceptance of germline genome editing for research purposes related to chronic diseases (60.9-66.7%) than for other research purposes (73.6-90.8%). Analysis of responses concerning expectations and concerns indicated that laypeople who would not accept genome editing of human embryos did not necessarily worry about "instrumentalization of the embryo." They also had substantially low expectations for recognized advantages of genome editing, including "advances in science" and "reduction of intractable diseases," compared with other groups of respondents. The assumptions shared among experts in conventional bioethical debates and policy discussions on human genome editing are not self-evident to laypeople.
已经对普通公众和人类基因组编辑专家进行了多项调查。然而,许多调查仅关注临床应用中的编辑,很少涉及将其用于基础研究。鉴于用于研究目的的基因组编辑对于实现临床基因组编辑不可或缺,了解公众对研究中基因组编辑的态度,特别是对可能引发伦理问题的人类胚胎基因组编辑的态度,有助于未来的社会讨论。对日本普通民众和研究人员进行了一项在线调查,以确定他们对用于研究目的的人类基因组编辑的看法。参与者被问及他们对基因组编辑目标(生殖细胞、多余的体外受精胚胎、研究用胚胎、体细胞)的接受程度;然后,那些回答“根据目的可接受”的人被问及他们在基因组编辑特定研究目的背景下的接受程度。参与者还被问及他们对人类基因组编辑的期望和担忧。共收到4424名普通民众和98名研究人员的回复。约28.2%-36.9%的普通民众对用于研究目的的基因组编辑表现出强烈抵制,无论其应用情况如何。相比之下,25.5%的研究人员仅对研究用胚胎的基因组编辑表现出抵制;这一比例明显高于其他三个目标(5.1%-9.2%)。约50.4%-63.4%回答“根据目的可接受”的普通民众批准了用于疾病研究的生殖系基因组编辑;然而,只有39.3%-42.8%的人批准在基础研究中进行基因组编辑以获取生物学知识。相比之下,研究人员对与慢性病相关的研究目的的生殖系基因组编辑的接受程度(60.9%-66.7%)低于其他研究目的(73.6%-90.8%)。对期望和担忧方面回复的分析表明,不接受人类胚胎基因组编辑的普通民众不一定担心“胚胎的工具化”。与其他受访者群体相比,他们对基因组编辑公认优势(包括“科学进步 ”和“减少难治性疾病”)的期望也很低。在传统生物伦理辩论和关于人类基因组编辑的政策讨论中,专家们共有的假设对普通民众来说并非不言而喻。